ACRX Latest Quarter's Earnings
| Announce Date | 11/08/2023 |
| EPS Normalized Actual | $-0.08 (Beat by $0.21) |
| EPS GAAP Actual | $-0.08 (Beat by $0.21) |
| Revenue Actual | $0.000442B |
| Revenue Surprise | Beat by $0.442M |
Upcoming Quarter's Earnings
| Announce Date | 09/30/2024 (Pre-Market) |
| EPS Normalized Estimate | $1.54141 |
| EPS GAAP Estimate | $1.54141 |
| Revenue Estimate | $0.00056925B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2025 | -0.895 | -0.96 | -1.09 | -0.7 | 2 |
| Dec 2024 | -0.92 | -0.93 | -1.09 | -0.75 | 2 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | -0.06 | 1.14 | 0.000442B | -15.61% | -0.11M |
| FQ4 2021 (Dec 2021) | -0.06 | 1.34 | -0.00186B | 139.68% | -4.41M |
| FQ3 2021 (Sep 2021) | -0.07 | 0 | 0.001862B | 26.53% | -0.69M |
| FQ2 2021 (Jun 2021) | -0.08 | 0 | 0.000443B | -560.05% | -1.46M |
| FQ1 2021 (Mar 2021) | -0.08 | 2.32 | 0.000511B | 24.46% | -0.58M |
| FQ4 2020 (Dec 2020) | -0.1 | -0.1 | 0.000738B | 35.64% | 0.74M |
| FQ3 2020 (Sep 2020) | -0.1 | -0.1 | 0.001368B | 55.56% | 1.37M |
| FQ2 2020 (Jun 2020) | -0.08 | 0.1 | 0.002924B | 67.82% | -2.19M |
Quarterly Estimates Summary
FQ4 Announce Date
09/30/2024 (Pre-Market)
Consensus EPS Estimates
1.54141
Consensus Revenue Estimates
0.00056925B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2024 (Sep 2024) | 1.54141 | -- | 1.78804 | 1.29478 | 1 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2024 (Sep 2024) | 0B | -- | 0B | 0B | 2 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
4
EPS # of Misses
2
EPS # of in-lines
2
Revenue # of Beats
2
Revenue # of Misses
6
Revenue # of in-lines
0
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | -1.2 | -0.06 | 1.14 | -1900% |
| FQ4 2021 (Dec 2021) | -1.4 | -0.06 | 1.34 | -2233.33% |
| FQ3 2021 (Sep 2021) | -0.07 | -0.07 | 0 | 0% |
| FQ2 2021 (Jun 2021) | -0.08 | -0.08 | 0 | 0% |
| FQ1 2021 (Mar 2021) | -2.4 | -0.08 | 2.32 | -2900% |
| FQ4 2020 (Dec 2020) | -0.1 | -0.1 | 100% | |
| FQ3 2020 (Sep 2020) | -0.1 | -0.1 | 100% | |
| FQ2 2020 (Jun 2020) | -0.18 | -0.08 | 0.1 | -125% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | $0B | $0B | $-0.11M | -24.43% |
| FQ4 2021 (Dec 2021) | $0B | $-0B | $-4.41M | 237.1% |
| FQ3 2021 (Sep 2021) | $0B | $0B | $-0.69M | -36.95% |
| FQ2 2021 (Jun 2021) | $0B | $0B | $-1.46M | -328.89% |
| FQ1 2021 (Mar 2021) | $0B | $0B | $-0.58M | -114.17% |
| FQ4 2020 (Dec 2020) | $0B | $0B | $0.74M | 100% |
| FQ3 2020 (Sep 2020) | $0B | $0B | $1.37M | 100% |
| FQ2 2020 (Jun 2020) | $0.01B | $0B | $-2.19M | -75% |
ACRX Ratings Summary
ACRX Quant Ranking
